TP53 and breast carcinoma: Therefore, the apparent abrogation of the association of p53 mutation with poor prognosis in the p53γ-positive population (but not in the p53β-positive population) indicates that only p53γ allows the identification of a subpopulation of breast cancer patients expressing mutant p53 with a better prognosis than expected.